TREM Receptors Connecting Bowel Inflammation to Neurodegenerative Disorders
Open Access
Abstract
Alterations in Triggering Receptors Expressed on Myeloid cells (TREM-1/2) are bound to a variety of infectious, sterile inflammatory, and degenerative conditions, ranging from inflammatory bowel disease (IBD) to neurodegenerative disorders. TREMs are emerging as key players in pivotal mechanisms often concurring in IBD and neurodegeneration, namely microbiota dysbiosis, leaky gut, and inflammation. In conditions of dysbiosis, compounds released by intestinal bacteria activate TREMs on macrophages, leading to an exuberant pro-inflammatory reaction up to damage in the gut barrier. In turn, TREM-positive activated macrophages along with inflammatory mediators may reach the brain through the blood, glymphatic system, circumventricular organs, or the vagus nerve via the microbiota-gut-brain axis. This leads to a systemic inflammatory response which, in turn, impairs the blood-brain barrier, while promoting further TREM-dependent neuroinflammation and, ultimately, neural injury. Nonetheless, controversial results still exist on the role of TREM-2 compared with TREM-1, depending on disease specificity, stage, and degree of inflammation. Therefore, the present review aimed to provide an update on the role of TREMs in the pathophysiology of IBD and neurodegeneration. The evidence here discussed the highlights of the potential role of TREMs, especially TREM-1, in bridging inflammatory processes in intestinal and neurodegenerative disorders.Keywords
Funding Information
- Ministero della Salute (Ricerca Corrente 2019)
This publication has 106 references indexed in Scilit:
- A framework for human microbiome researchNature, 2012
- TREM‐2, triggering receptor expressed on myeloid cell‐2, negatively regulates TLR responses in dendritic cellsEuropean Journal of Immunology, 2011
- Gut Microbiota in Health and DiseasePhysiological Reviews, 2010
- Efficient colonic mucosal wound repair requires Trem2 signalingProceedings of the National Academy of Sciences, 2009
- Identification of soluble TREM-2 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammationBrain, 2008
- Triggering receptor expressed on myeloid cell-like transcript 2 (TLT-2) is a counter-receptor for B7-H3 and enhances T cell responsesProceedings of the National Academy of Sciences, 2008
- Autophagy fights disease through cellular self-digestionNature, 2008
- TREM-1–expressing intestinal macrophages crucially amplify chronic inflammation in experimental colitis and inflammatory bowel diseasesJournal of Clinical Investigation, 2007
- TREM2-Transduced Myeloid Precursors Mediate Nervous Tissue Debris Clearance and Facilitate Recovery in an Animal Model of Multiple SclerosisPLOS Medicine, 2007
- TREMs in the immune system and beyondNature Reviews Immunology, 2003